News search
Research 18 Nov 2021 Immune therapy based on nasal administration of a preparation of dead bacteria called MV130 prevents death in experimental animals infected with the SARS-CoV-2 coronavirus and increases the immunogenicity of COVID-19 vaccines |
Research 7 May 2020 Research could change standard of care protocols to prevent clotting associated with coronavirus |